ZA965998B - 2-(4-Substituted)-benzylamino-2-methyl-propanamide derivatives - Google Patents

2-(4-Substituted)-benzylamino-2-methyl-propanamide derivatives

Info

Publication number
ZA965998B
ZA965998B ZA965998A ZA965998A ZA965998B ZA 965998 B ZA965998 B ZA 965998B ZA 965998 A ZA965998 A ZA 965998A ZA 965998 A ZA965998 A ZA 965998A ZA 965998 B ZA965998 B ZA 965998B
Authority
ZA
South Africa
Prior art keywords
benzylamino
substituted
methyl
propanamide derivatives
propanamide
Prior art date
Application number
ZA965998A
Other languages
English (en)
Inventor
Paolo Pevarello
Raffaella Amici
Mario Varasi
Alberto Bonsignori
Patricia Salvati
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10778352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA965998(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of ZA965998B publication Critical patent/ZA965998B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/33—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
    • C07C323/35—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group
    • C07C323/36—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group the sulfur atom of the sulfide group being further bound to an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA965998A 1995-07-27 1996-07-15 2-(4-Substituted)-benzylamino-2-methyl-propanamide derivatives ZA965998B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9515412.6A GB9515412D0 (en) 1995-07-27 1995-07-27 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives

Publications (1)

Publication Number Publication Date
ZA965998B true ZA965998B (en) 1997-01-31

Family

ID=10778352

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965998A ZA965998B (en) 1995-07-27 1996-07-15 2-(4-Substituted)-benzylamino-2-methyl-propanamide derivatives

Country Status (27)

Country Link
US (1) US5945454A (fr)
EP (1) EP0842143B3 (fr)
JP (1) JP4040089B2 (fr)
KR (1) KR100412747B1 (fr)
CN (1) CN1085659C (fr)
AR (1) AR003469A1 (fr)
AT (1) ATE202078T1 (fr)
AU (1) AU711309B2 (fr)
BR (1) BR9609849B1 (fr)
CA (1) CA2226894C (fr)
DE (2) DE69613377D1 (fr)
DK (1) DK0842143T5 (fr)
EA (1) EA001322B1 (fr)
ES (1) ES2159749T7 (fr)
GB (1) GB9515412D0 (fr)
GR (1) GR3036559T3 (fr)
HU (1) HU227806B1 (fr)
IL (1) IL122705A (fr)
MX (1) MX9800718A (fr)
NO (1) NO324273B1 (fr)
NZ (1) NZ313185A (fr)
PL (1) PL184302B1 (fr)
PT (1) PT842143E (fr)
SI (1) SI0842143T1 (fr)
UA (1) UA44331C2 (fr)
WO (1) WO1997005102A1 (fr)
ZA (1) ZA965998B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
MXPA00004919A (es) * 1997-11-21 2002-10-17 Euro Celtique Sa 2-aminoacetamidas sustituidas y uso de las mismas.
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
EP1169060B1 (fr) 1999-04-09 2005-08-31 Euro-Celtique S.A. Composition de blocage du canal sodique et leur utilisation
CN1426397A (zh) * 2000-03-31 2003-06-25 欧洲凯尔特股份有限公司 氨基吡啶类化合物及其作为抗惊厥剂和钠通道阻滞剂的应用
PT1423168E (pt) 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
EP1438956A1 (fr) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Dérivés alpha-aminoamides en tant qu'agents antimigraine
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
EP1524267A1 (fr) 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Heterocycles benzyleaminoalkylene substitues
DE602004017206D1 (de) 2003-10-23 2008-11-27 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
EP1557166A1 (fr) * 2004-01-21 2005-07-27 Newron Pharmaceuticals S.p.A. Derives d'alpha-aminoamides pour le traitement des désordres de l'appareil urinaire inférieur
EP1588704A1 (fr) * 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Dérivés d'alpha-aminoamides utiles dans le traitement de l'acroparesthésie nocturne et des troubles de toxicomanie
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
JP2009513603A (ja) * 2005-10-26 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｍｃｈ拮抗活性を有する（ヘテロ）アリール化合物及びこの化合物を含む医薬
CA2629065C (fr) 2005-12-22 2013-08-06 Newron Pharmaceuticals S.P.A. Derives 2-phenylethylamino en tant que modulateurs du canal calcium et/ou sodium
EP1870097A1 (fr) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Dérivés d'alpha-aminoamide pour le traitement de troubles cognitifs
EP2046451A1 (fr) * 2006-07-28 2009-04-15 Alcon Research, Ltd. Inhibiteurs de monoamine oxydase utiles pour le traitement de troubles de la rétine externe
MX2009013119A (es) 2007-06-15 2010-03-04 Newron Pharm Spa Derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos y su uso como moduladores del canal de sodio y/o potasio.
DK2563355T3 (en) * 2010-04-27 2016-09-12 Newron Pharm Spa A process for the preparation of ralfinamide-methanesulphonate or R-enantiomers thereof.
WO2016198691A1 (fr) 2015-06-11 2016-12-15 Basilea Pharmaceutica Ag Inhibiteurs de la pompe à efflux et utilisations thérapeutiques correspondantes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation

Also Published As

Publication number Publication date
DK0842143T5 (da) 2009-06-02
HUP9900351A2 (hu) 1999-06-28
AU711309B2 (en) 1999-10-07
CA2226894C (fr) 2009-03-31
JP2000500732A (ja) 2000-01-25
ES2159749T3 (es) 2001-10-16
GR3036559T3 (en) 2001-12-31
HUP9900351A3 (en) 1999-11-29
ES2159749T7 (es) 2009-06-18
WO1997005102A1 (fr) 1997-02-13
MX9800718A (es) 1998-04-30
KR100412747B1 (ko) 2004-04-28
CN1085659C (zh) 2002-05-29
KR19990035843A (ko) 1999-05-25
PL324639A1 (en) 1998-06-08
AU6418796A (en) 1997-02-26
HU227806B1 (en) 2012-03-28
DK0842143T3 (da) 2001-07-23
CN1192199A (zh) 1998-09-02
PL184302B1 (pl) 2002-09-30
ATE202078T1 (de) 2001-06-15
US5945454A (en) 1999-08-31
NO324273B1 (no) 2007-09-17
NO980290D0 (no) 1998-01-22
JP4040089B2 (ja) 2008-01-30
DE69613377D1 (de) 2001-07-19
EP0842143A1 (fr) 1998-05-20
NZ313185A (en) 2000-05-26
EP0842143B1 (fr) 2001-06-13
DE69613377T2 (de) 2001-09-20
DE69613377T4 (de) 2009-08-13
GB9515412D0 (en) 1995-09-27
UA44331C2 (uk) 2002-02-15
PT842143E (pt) 2001-10-30
IL122705A (en) 2001-01-28
EP0842143B3 (fr) 2009-02-18
AU711309C (en) 1997-02-26
SI0842143T1 (fr) 2001-08-31
EA001322B1 (ru) 2001-02-26
CA2226894A1 (fr) 1997-02-13
BR9609849B1 (pt) 2010-05-18
IL122705A0 (en) 1998-08-16
BR9609849A (pt) 1999-03-16
EA199800170A1 (ru) 1998-08-27
AR003469A1 (es) 1998-08-05
NO980290L (no) 1998-01-22

Similar Documents

Publication Publication Date Title
ZA975675B (en) Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one
EG24195A (en) Heterocyclic compounds
GR3036559T3 (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
ZA9610020B (en) Heterocyclic compounds
GB9512697D0 (en) Heterocyclic compounds
GB9504361D0 (en) Heterocyclic compounds
GB9405533D0 (en) Heterocyclic derivatives
ZA962734B (en) Heterocyclic compounds
GB9511098D0 (en) Heterocyclic derivatives
GB9502610D0 (en) Heterocyclic derivatives
GB9511052D0 (en) Heterocyclic derivatives
GB9519666D0 (en) Heterocyclic derivatives
AU705798C (en) Novel heterocyclic derivatives
AU7995898A (en) Novel heterocyclic derivatives
GB9425797D0 (en) Heterocyclic derivatives
GB9419062D0 (en) Heterocyclic derivatives
GB9424295D0 (en) Heterocyclic derivatives
GB9419339D0 (en) Heterocyclic derivatives
GB9421548D0 (en) Heterocyclic derivatives
GB9419343D0 (en) Heterocyclic derivatives
GB9419524D0 (en) Heterocyclic derivatives
GB9420755D0 (en) Heterocyclic derivatives
GB9420783D0 (en) Heterocyclic derivatives
GB9402127D0 (en) Heterocyclic derivatives
GB9407431D0 (en) Heterocyclic derivatives